is fda banning semaglutide ๐จ Moves to Permanently Shut Down Compounded GLP-1s The FDA taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Semaglutide shortage ends as FDA
Description
Nutrients 2023;15:1510
However, some studies on injections have found that people sometimes find injections in the thigh more painful than in the abdomen
Similar movement was also seen for the C-terminal half of tirzepatide (2.1 measured by the C of I27 P )
In studies of obese dogs, daily doses significantly reduced food intake, body weight, and post-meal blood sugar spikes
The FDA isnt deciding whether these compounds are safe
This might include proof that other treatments have failed or that you have comorbidities like heart disease that make the GLP-1 the best option
